Skip to main content
Signal8

Haleon plc (HLN)

Sector: Perfumes, Cosmetics & Other Toilet Preparations

Industry: Drug Manufacturers - Specialty & Generic

Haleon plc logo

Haleon plc

NYSE:HLNHealthcare
Pre+0.55%$9.19
Close$9.14-0.11%AH$9.14+0.55%since
Mkt Cap$40.17B
Float747.74M
O/S4.4B
PM VOL7K sh
$ Vol≈$64K
RVOL0.22×
Inst Own13.9%
SI2.5%
Div Yield2.17%
Dilution
Haleon plc logoNYSE:HLNPre$9.19+0.55%
Historical Data
DateOpenHighLowCloseVolume
Nov 6, 20268.919.158.889.1418,678,558
Nov 5, 20269.239.369.099.1538,366,776
Nov 4, 20269.049.279.009.2328,018,445
Nov 3, 20268.878.938.808.8431,984,190
Nov 2, 20268.658.848.638.7634,941,419
Oct 30, 20268.668.798.618.6632,525,872
Oct 29, 20268.558.758.388.5756,763,396
Oct 28, 202610.0010.119.9610.0022,189,963
Oct 27, 202610.1310.1510.0610.0815,855,216
Oct 26, 202610.2310.3210.1910.2015,270,636
Oct 23, 202610.3010.3410.2210.2715,066,424
Oct 22, 202610.1310.3910.1210.3714,622,373
Oct 21, 202610.1110.1410.0210.0213,006,393
Oct 20, 202610.1610.2510.1210.1718,761,639
Oct 19, 202610.0610.1910.0510.1420,191,422
Oct 16, 20269.9810.139.9610.1317,995,342
Oct 15, 20269.9710.069.909.9418,334,710
Oct 14, 20269.539.719.499.6813,842,012
Oct 13, 20269.559.599.429.4413,519,881
Oct 12, 20269.359.519.339.5019,371,464
Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
Not available
Ratings Distribution
BUY
3
HOLD
1
SELL
0
TOTAL4
Insider Trades
No insider transactions for this companyForeign private issuers and non-reporting entities don't file Form 4/5.
Shareholders
13.9%
Institutional
(657)
0.0%
Insiderⓘ
(0)
0.0%
5%+ Owners
(0)
86.1%
Unattributed (incl. retail)ⓘ
Institutional13.9%
Unattributed (incl. retail)86.1%
Sources: 13F, 13D/13GO/S: 4.4B · checked 8 Nov 2026 · market-data provider
Insiders & Institutional Holders

Top institutional holders

About

Haleon plc is a significant global entity in the consumer healthcare sector, engaging in the entire process from scientific research and development to the production and worldwide distribution of various wellness goods.

The company's reach extends across North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific region.

Its diverse product portfolio encompasses therapeutic solutions for oral care, pain management, respiratory well-being, and digestive health, alongside a comprehensive range of vitamins, minerals, and other dietary supplements. Noteworthy brands within its collection include Panadol, Voltaren, Advil, Otrivin, Theraflu, Sensodyne, Polident, parodontax, and Centrum. Established in 2021, the company was initially known as DRVW 2022 plc before officially changing its name to Haleon plc in February 2022.

It is headquartered in Brentford, United Kingdom.

Key Metrics
Market Cap$40.17B
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership13.91%

based on 4.40B shares outstanding

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ExchangeNYSE
CountryGBGB
IPO DateJul 25, 2022
Shares Outstanding4.40B
Authorized Shares
Float747.74M
52-Week Range
$8.38$11.28
$9.14(26th percentile)
Volume
Average Daily Volume22.97M
18.68M today vs 22.97M avg(-19%)

30d Avg

22.97M

60d Avg

21.99M

90d Avg

18.01M

Earnings
Dividend History
TTM Yield
2.17%
Paid semi-annually
Annual (LTM)
$0.20
Latest
$0.0647
Aug 14, 26
5Y Growth
--
Compliance Status
Loading compliance data...